GKOS – Glaukos Corporation

Glaukos Corporation

GKOS

$125.88

Name : Glaukos Corporation

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $7,105,170,432.00

EPSttm : -2.77

Glaukos Corporation

$125.88

20.01%

$31.48

Float Short %

6.31

Margin Of Safety %

Put/Call OI Ratio

1.72

EPS Next Q Diff

-0.09

EPS Last/This Y

EPS This/Next Y

0.7

Price

125.92

Target Price

168.62

Analyst Recom

1.6

Performance Q

-8.1

Relative Volume

7.19

Beta

0.95

Ticker: GKOS

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-01-23	GKOS	161.22	0.76	2.48	5669
2025-01-24	GKOS	160.2	0.77	3.63	5702
2025-01-27	GKOS	157	0.87	2.13	6130
2025-01-28	GKOS	159.57	0.94	1.94	6514
2025-01-29	GKOS	158.95	0.95	0.77	6547
2025-01-30	GKOS	157.85	0.94	1.75	6589
2025-01-31	GKOS	156.34	0.94	2.78	6600
2025-02-03	GKOS	156.04	0.97	0.24	6752
2025-02-04	GKOS	154.25	0.96	0.23	6834
2025-02-05	GKOS	156.95	0.96	0.50	6843
2025-02-06	GKOS	155.33	0.96	0.23	6847
2025-02-07	GKOS	153.09	0.95	0.46	6862
2025-02-10	GKOS	149.9	0.96	0.94	6859
2025-02-11	GKOS	145.16	0.96	10.14	6903
2025-02-12	GKOS	143.76	1.14	1.98	7641
2025-02-13	GKOS	146.35	1.15	38.72	9650
2025-02-14	GKOS	153.23	1.71	1.35	12327
2025-02-18	GKOS	152.98	1.72	9.32	12450
2025-02-19	GKOS	160.72	1.78	3.11	12761
2025-02-20	GKOS	157.37	1.93	2.51	15462
2025-02-21	GKOS	125.92	1.72	5.95	16817
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-01-23	GKOS	161.22	39.7	70.0	-1.83
2025-01-24	GKOS	160.30	39.7	70.9	-1.83
2025-01-27	GKOS	157.02	39.7	71.8	-1.83
2025-01-28	GKOS	159.49	39.7	69.4	-1.83
2025-01-29	GKOS	158.97	39.7	70.8	-1.83
2025-01-30	GKOS	157.75	39.7	71.0	-1.83
2025-01-31	GKOS	156.40	39.7	71.1	-1.83
2025-02-03	GKOS	156.08	39.7	70.6	-1.83
2025-02-04	GKOS	154.37	39.7	71.2	-1.83
2025-02-05	GKOS	157.27	39.7	69.1	-1.83
2025-02-06	GKOS	155.26	39.7	71.3	-1.83
2025-02-07	GKOS	153.11	39.7	71.4	-1.83
2025-02-10	GKOS	150.01	39.7	71.8	-1.83
2025-02-11	GKOS	145.17	39.7	72.6	-1.83
2025-02-12	GKOS	143.73	39.7	71.2	-1.83
2025-02-13	GKOS	146.38	39.7	69.2	-1.83
2025-02-14	GKOS	153.20	39.7	67.4	-1.83
2025-02-18	GKOS	152.98	39.7	70.6	-1.83
2025-02-19	GKOS	160.58	39.7	67.1	-1.83
2025-02-20	GKOS	157.33	38.3	71.8	-1.83
2025-02-21	GKOS	125.92	38.3	83.9	-1.83
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-01-23	GKOS	-2.76	1.61	5.72
2025-01-24	GKOS	-2.76	1.61	5.72
2025-01-27	GKOS	-2.76	1.05	5.72
2025-01-28	GKOS	-2.76	1.05	6.07
2025-01-29	GKOS	-2.76	1.05	6.07
2025-01-30	GKOS	-2.76	1.05	6.07
2025-01-31	GKOS	-2.76	1.05	6.07
2025-02-03	GKOS	-2.76	0.90	6.07
2025-02-04	GKOS	-2.76	0.90	6.07
2025-02-05	GKOS	-2.76	0.90	6.07
2025-02-06	GKOS	-2.76	0.90	6.07
2025-02-07	GKOS	-2.76	0.90	6.07
2025-02-10	GKOS	-2.76	0.89	6.09
2025-02-11	GKOS	-2.61	0.89	6.09
2025-02-12	GKOS	-2.61	0.89	6.33
2025-02-13	GKOS	-1.48	0.89	6.33
2025-02-14	GKOS	-1.56	0.89	6.32
2025-02-18	GKOS	-1.56	2.50	6.31
2025-02-19	GKOS	-1.61	2.50	6.31
2025-02-20	GKOS	-1.46	2.50	6.31
2025-02-21	GKOS	-1.46	2.50	6.31
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.28

Avg. EPS Est. Current Quarter

-0.38

Avg. EPS Est. Next Quarter

-0.37

Insider Transactions

-1.46

Institutional Transactions

2.5

Beta

0.95

Average Sales Estimate Current Quarter

100

Average Sales Estimate Next Quarter

107

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

23.1

Max Drawdown 5-Year %

-64.3

Target Price

168.62

P/E

Forward P/E

PEG

P/S

18.1

P/B

9.26

P/Free Cash Flow

EPS

-2.81

Average EPS Est. Cur. Y

-1.83

EPS Next Y. (Est.)

-1.13

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-38.17

Relative Volume

7.19

Return on Equity vs Sector %

-41.6

Return on Equity vs Industry %

-34.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

83.9

Glaukos Corporation

Sector: Healthcare

Industry: Medical Devices

Employees:

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

stock quote shares GKOS – Glaukos Corporation Stock Price stock today

news today GKOS – Glaukos Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch GKOS – Glaukos Corporation yahoo finance google finance

stock history GKOS – Glaukos Corporation invest stock market

stock prices GKOS premarket after hours

ticker GKOS fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

GKOS – Glaukos Corporation

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: GKOS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y